UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer

Journal of clinical oncology, 2015-12, Vol.33 (34), p.4032-4038

2015

Volltextzugriff (PDF)

Shedding light on cutaneous metastases

Journal of the European Academy of Dermatology and Venereology, 2024-07, Vol.38 (7), p.1240-1241

2024

Volltextzugriff (PDF)

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

Journal of clinical oncology, 2012-02, Vol.30 (6), p.593-599

2012

Volltextzugriff (PDF)

Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial

The lancet oncology, 2016-09, Vol.17 (9), p.1248-1260

2016

Volltextzugriff (PDF)

Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer

Oral oncology, 2013-01, Vol.49 (1), p.79-85

2013

Volltextzugriff (PDF)

Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases

Acta oncologica, 2018-07, Vol.57 (7), p.874-882

2018

Volltextzugriff (PDF)

Anti–PD-1/anti–CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8⁺ T cell trafficking

Proceedings of the National Academy of Sciences - PNAS, 2018-02, Vol.115 (7), p.E1540-E1549

2018

Volltextzugriff (PDF)

Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin

Journal of clinical oncology, 2013-09, Vol.31 (26), p.3182-3190

2013

Volltextzugriff (PDF)

Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma

The Journal of pathology, 2013-07, Vol.230 (3), p.261-269

2013

Volltextzugriff (PDF)

TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma

JNCI : Journal of the National Cancer Institute, 2014-09, Vol.106 (9), p.1

2014

Volltextzugriff (PDF)

A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients

Cancer immunology research, 2019-07, Vol.7 (7), p.1162-1174

2019

Volltextzugriff (PDF)

Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients

The Journal of experimental medicine, 2019-05, Vol.216 (5), p.1091-1107

2019

Volltextzugriff (PDF)

Rates of cutaneous metastases from different internal malignancies: Experience from a Taiwanese medical center

Journal of the American Academy of Dermatology, 2009-03, Vol.60 (3), p.379-387

2009

Volltextzugriff (PDF)

Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases

Cancer research (Chicago, Ill.), 2012-08, Vol.72 (16), p.3997-4007

2012

Volltextzugriff (PDF)

Receptor conversion in distant breast cancer metastases

Breast cancer research : BCR, 2010-09, Vol.12 (5), p.R75-R75, Article R75

2010

Volltextzugriff (PDF)

Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases

Annals of surgical oncology, 2016-04, Vol.23 (4), p.1309-1319

2016

Volltextzugriff (PDF)

Transcription Factor Foxo1 Is a Negative Regulator of Natural Killer Cell Maturation and Function

Immunity (Cambridge, Mass.), 2015-03, Vol.42 (3), p.457-470

2015

Volltextzugriff (PDF)

Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K–mutant advanced or metastatic melanoma

European journal of cancer (1990), 2019-03, Vol.109, p.61-69

2019

Volltextzugriff (PDF)

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study

Breast cancer research : BCR, 2011-09, Vol.13 (5), p.R87-R87, Article R87

2011

Volltextzugriff (PDF)

Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial

The lancet oncology, 2012-09, Vol.13 (9), p.897-905

2012

Volltextzugriff (PDF)

Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy

JNCI : Journal of the National Cancer Institute, 2019-02, Vol.111 (2), p.180-188

2019

Volltextzugriff (PDF)

Zosteriform cutaneous metastasis: a case report of ovarian neoplasms

EJD. European journal of dermatology, 2024-06, Vol.34 (3), p.332-334

2024

Volltextzugriff (PDF)

Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment

The Journal of immunology (1950), 2012-12, Vol.189 (12), p.5533-5540

2012

Volltextzugriff (PDF)

The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma

Medical oncology (Northwood, London, England), 2018-03, Vol.35 (3), p.25-9, Article 25

2018

Volltextzugriff (PDF)

1 – 25 von 13.416

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11.873)
Mit Volltextzugriff
(9.500)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(12.870)
Science & Technology
(10.354)
Life Sciences & Biomedicine
(10.259)
Male
(7.660)
Female
(7.287)
Skin Neoplasms - Pathology
(7.260)
Middle Aged
(6.242)
Melanoma - Secondary
(5.521)
Aged
(5.293)
Dermatology
(4.891)
Biological And Medical Sciences
(4.424)
Medical Sciences
(4.397)
Skin Neoplasms - Secondary
(4.266)
Adult
(4.137)
Oncology
(3.315)
Tumors Of The Skin And Soft Tissue. Premalignant Lesions
(2.532)
Melanoma
(2.473)
Melanoma - Pathology
(2.368)
Lymphatic Metastasis
(2.247)
Aged, 80 And Over
(2.159)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(13.392)
Ovid
(6.940)
Ingenta
(5.877)
EZB Electronic Journals Library
(4.501)
Publisher website
(3.042)
IngentaConnect Journals
(3.011)
Wiley Online Library
(2.785)
Elsevier ScienceDirect Journals Complete
(2.384)
Wiley Online Library
(2.307)
Springer journals
(1.373)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.366)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(982)
Oxford journals
(547)
BMJ Publishing
(322)
Sage Journals
(317)
Taylor & Francis Journals
(310)
Springer Book Series (Lecture Notes)
(284)
Nature Journals
(272)
Taylor & Francis Online
(269)
Taylor & Francis
(262)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(22)

Menü

Weitere Dienste

Einstellungen

Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008–2016

Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer

Shedding light on cutaneous metastases

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial

Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer

Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases

Anti–PD-1/anti–CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8⁺ T cell trafficking

Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin

Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma

TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma

A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients

Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients

Rates of cutaneous metastases from different internal malignancies: Experience from a Taiwanese medical center

Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases

Receptor conversion in distant breast cancer metastases

Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases

Transcription Factor Foxo1 Is a Negative Regulator of Natural Killer Cell Maturation and Function

Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K–mutant advanced or metastatic melanoma

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study

Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial

Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy

Zosteriform cutaneous metastasis: a case report of ovarian neoplasms

Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment

The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma

Suchergebnisse filtern